Adipocyte hypertrophy in mesenchymal stem cells from infants of mothers with obesity

Abstract

AbstractObjectiveFat content of adipocytes derived from infant umbilical cord mesenchymal stem cells (MSCs) predicts adiposity in children through 4 to 6 years of age. This study tested the hypothesis that MSCs from infants born to mothers with obesity (Ob‐MSCs) exhibit adipocyte hypertrophy and perturbations in genes regulating adipogenesis compared with MSCs from infants of mothers with normal weight (NW‐MSCs).MethodsAdipogenesis was induced in MSCs embedded in three‐dimensional hydrogel structures, and cell size and number were measured by three‐dimensional imaging. Proliferation and protein markers of proliferation and adipogenesis in undifferentiated and adipocyte differentiating cells were measured. RNA sequencing was performed to determine pathways linked to adipogenesis phenotype.ResultsIn undifferentiated MSCs, greater zinc finger protein (Zfp)423 protein content was observed in Ob‐ versus NW‐MSCs. Adipocytes from Ob‐MSCs were larger but fewer than adipocytes from NW‐MSCs. RNA sequencing analysis showed that Zfp423 protein correlated with mRNA expression of genes enriched for cell cycle, MSC lineage specification, inflammation, and metabolism pathways. MSC proliferation was not different before differentiation but declined faster in Ob‐MSCs upon adipogenic induction.ConclusionsOb‐MSCs have an intrinsic propensity for adipocyte hypertrophy and reduced hyperplasia during adipogenesis in vitro, perhaps linked to greater Zfp423 content and changes in cell cycle pathway gene expression.